Studies in breast and oral squamous cell carcinoma cells showed that silencing of miR-221 enhanced the sensitivity to tamoxifen and adriamycin through upregulation of the tissue inhibitor of metalloproteinase-3 (TIMP3) [113, 114]. Here, TIMP3 is linked to oral cavity squamous cell carcinoma.